Functional frontal lobectomy in the surgical treatment of pharmacoresistant frontal lobe epilepsy: how I do it

Francesca Battista,Alice Esposito,Giovanni Muscas,Alessandro Della Puppa
DOI: https://doi.org/10.1007/s00701-024-06176-x
2024-07-19
Acta Neurochirurgica
Abstract:Frontal lobe epilepsy is pharmacoresistant in 30% of cases, constituting 10–20% of epilepsy surgeries. For cases of no lesional epilepsy (negative MRI), frontal lobectomy is a crucial treatment, historically involving Frontal Anatomical Lobectomy (AFL) with a 33.3% complication risk and 55.7% seizure control.
surgery,clinical neurology
What problem does this paper attempt to address?